Global Oral Vaccines Market Growth 2022-2028
As the global economy mends, the 2021 growth of Oral Vaccines will have significant change from previous year. According to our latest study, the global Oral Vaccines market size is USD million in 2022 from USD 2420.2 million in 2021, with a change of % between 2021 and 2022. The global Oral Vaccines market size will reach USD 3284.9 million in 2028, growing at a CAGR of 4.5% over the analysis period.
The United States Oral Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Vaccines market, reaching US$ million by the year 2028. As for the Europe Oral Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Vaccines players cover Merck, GSK, Sanofi, and Lanzhou Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Public
Private
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Oral Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.3 Oral Vaccines Sales by Type
2.3.1 Global Oral Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Vaccines Sale Price by Type (2017-2022)
2.4 Oral Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Vaccines Sales by Application
2.5.1 Global Oral Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Vaccines Sale Price by Application (2017-2022)
3 Global Oral Vaccines by Company
3.1 Global Oral Vaccines Breakdown Data by Company
3.1.1 Global Oral Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Oral Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Oral Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Vaccines Revenue by Company (2020-2022)
3.2.2 Global Oral Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Oral Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Vaccines Product Location Distribution
3.4.2 Players Oral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Vaccines by Geographic Region
4.1 World Historic Oral Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Vaccines Annual Revenue by Geographic Region
4.2 World Historic Oral Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Vaccines Annual Revenue by Country/Region
4.3 Americas Oral Vaccines Sales Growth
4.4 APAC Oral Vaccines Sales Growth
4.5 Europe Oral Vaccines Sales Growth
4.6 Middle East & Africa Oral Vaccines Sales Growth
5 Americas
5.1 Americas Oral Vaccines Sales by Country
5.1.1 Americas Oral Vaccines Sales by Country (2017-2022)
5.1.2 Americas Oral Vaccines Revenue by Country (2017-2022)
5.2 Americas Oral Vaccines Sales by Type
5.3 Americas Oral Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Vaccines Sales by Region
6.1.1 APAC Oral Vaccines Sales by Region (2017-2022)
6.1.2 APAC Oral Vaccines Revenue by Region (2017-2022)
6.2 APAC Oral Vaccines Sales by Type
6.3 APAC Oral Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Vaccines by Country
7.1.1 Europe Oral Vaccines Sales by Country (2017-2022)
7.1.2 Europe Oral Vaccines Revenue by Country (2017-2022)
7.2 Europe Oral Vaccines Sales by Type
7.3 Europe Oral Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Vaccines by Country
8.1.1 Middle East & Africa Oral Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Vaccines Sales by Type
8.3 Middle East & Africa Oral Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Vaccines
10.3 Manufacturing Process Analysis of Oral Vaccines
10.4 Industry Chain Structure of Oral Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Vaccines Distributors
11.3 Oral Vaccines Customer
12 World Forecast Review for Oral Vaccines by Geographic Region
12.1 Global Oral Vaccines Market Size Forecast by Region
12.1.1 Global Oral Vaccines Forecast by Region (2023-2028)
12.1.2 Global Oral Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Vaccines Forecast by Type
12.7 Global Oral Vaccines Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Oral Vaccines Product Offered
13.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Vaccines Product Offered
13.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Vaccines Product Offered
13.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Oral Vaccines Product Offered
13.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Oral Vaccines Product Offered
13.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Oral Vaccines Product Offered
13.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Oral Vaccines Product Offered
13.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Oral Vaccines Product Offered
13.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Oral Vaccines Product Offered
13.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Oral Vaccines Product Offered
13.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Oral Vaccines Product Offered
13.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Oral Vaccines Product Offered
13.12.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Oral Vaccines Product Offered
13.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Oral Vaccines Product Offered
13.14.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Offered
13.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Oral Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Global Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 7. Global Oral Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global Oral Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oral Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global Oral Vaccines Sale Price by Type (2017-2022) & (USD/K Doses)
Table 11. Global Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 12. Global Oral Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global Oral Vaccines Revenue by Application (2017-2022)
Table 14. Global Oral Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global Oral Vaccines Sale Price by Application (2017-2022) & (USD/K Doses)
Table 16. Global Oral Vaccines Sales by Company (2020-2022) & (M Doses)
Table 17. Global Oral Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global Oral Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oral Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global Oral Vaccines Sale Price by Company (2020-2022) & (USD/K Doses)
Table 21. Key Manufacturers Oral Vaccines Producing Area Distribution and Sales Area
Table 22. Players Oral Vaccines Products Offered
Table 23. Oral Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oral Vaccines Sales by Geographic Region (2017-2022) & (M Doses)
Table 27. Global Oral Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oral Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oral Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oral Vaccines Sales by Country/Region (2017-2022) & (M Doses)
Table 31. Global Oral Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oral Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oral Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 35. Americas Oral Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas Oral Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oral Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 39. Americas Oral Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 41. Americas Oral Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC Oral Vaccines Sales by Region (2017-2022) & (M Doses)
Table 43. APAC Oral Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC Oral Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oral Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 47. APAC Oral Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 49. APAC Oral Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 51. Europe Oral Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe Oral Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oral Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 55. Europe Oral Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 57. Europe Oral Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 59. Middle East & Africa Oral Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oral Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 63. Middle East & Africa Oral Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 65. Middle East & Africa Oral Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oral Vaccines
Table 67. Key Market Challenges & Risks of Oral Vaccines
Table 68. Key Industry Trends of Oral Vaccines
Table 69. Oral Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oral Vaccines Distributors List
Table 72. Oral Vaccines Customer List
Table 73. Global Oral Vaccines Sales Forecast by Region (2023-2028) & (M Doses)
Table 74. Global Oral Vaccines Sales Market Forecast by Region
Table 75. Global Oral Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oral Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oral Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 78. Americas Oral Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oral Vaccines Sales Forecast by Region (2023-2028) & (M Doses)
Table 80. APAC Oral Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oral Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 82. Europe Oral Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oral Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 84. Middle East & Africa Oral Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oral Vaccines Sales Forecast by Type (2023-2028) & (M Doses)
Table 86. Global Oral Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oral Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oral Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oral Vaccines Sales Forecast by Application (2023-2028) & (M Doses)
Table 90. Global Oral Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oral Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oral Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. Merck Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Oral Vaccines Product Offered
Table 95. Merck Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. GSK Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Oral Vaccines Product Offered
Table 100. GSK Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. Sanofi Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi Oral Vaccines Product Offered
Table 105. Sanofi Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Lanzhou Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Lanzhou Institute Oral Vaccines Product Offered
Table 110. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 111. Lanzhou Institute Main Business
Table 112. Lanzhou Institute Latest Developments
Table 113. Serum Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute Oral Vaccines Product Offered
Table 115. Serum Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 116. Serum Institute Main Business
Table 117. Serum Institute Latest Developments
Table 118. Valneva Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Valneva Oral Vaccines Product Offered
Table 120. Valneva Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 121. Valneva Main Business
Table 122. Valneva Latest Developments
Table 123. Shanghai United Cell Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai United Cell Oral Vaccines Product Offered
Table 125. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 126. Shanghai United Cell Main Business
Table 127. Shanghai United Cell Latest Developments
Table 128. Bibcol Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Bibcol Oral Vaccines Product Offered
Table 130. Bibcol Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 131. Bibcol Main Business
Table 132. Bibcol Latest Developments
Table 133. PaxVax Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. PaxVax Oral Vaccines Product Offered
Table 135. PaxVax Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 136. PaxVax Main Business
Table 137. PaxVax Latest Developments
Table 138. Vabiotech Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Vabiotech Oral Vaccines Product Offered
Table 140. Vabiotech Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 141. Vabiotech Main Business
Table 142. Vabiotech Latest Developments
Table 143. Tiantan Biological Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Tiantan Biological Oral Vaccines Product Offered
Table 145. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 146. Tiantan Biological Main Business
Table 147. Tiantan Biological Latest Developments
Table 148. EuBiologics Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. EuBiologics Oral Vaccines Product Offered
Table 150. EuBiologics Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 151. EuBiologics Main Business
Table 152. EuBiologics Latest Developments
Table 153. Panacea Biotec Ltd Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Panacea Biotec Ltd Oral Vaccines Product Offered
Table 155. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 156. Panacea Biotec Ltd Main Business
Table 157. Panacea Biotec Ltd Latest Developments
Table 158. Bio-Med Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Bio-Med Oral Vaccines Product Offered
Table 160. Bio-Med Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 161. Bio-Med Main Business
Table 162. Bio-Med Latest Developments
Table 163. Halfkin Bio-Pharmaceuticals Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Offered
Table 165. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 166. Halfkin Bio-Pharmaceuticals Main Business
Table 167. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Oral Vaccines
Figure 2. Oral Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Vaccines Sales Growth Rate 2017-2028 (M Doses)
Figure 7. Global Oral Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Rotavirus Vaccine
Figure 10. Product Picture of Cholera Vaccine
Figure 11. Product Picture of Oral Polio Vaccine
Figure 12. Global Oral Vaccines Sales Market Share by Type in 2021
Figure 13. Global Oral Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. Oral Vaccines Consumed in Public
Figure 15. Global Oral Vaccines Market: Public (2017-2022) & (M Doses)
Figure 16. Oral Vaccines Consumed in Private
Figure 17. Global Oral Vaccines Market: Private (2017-2022) & (M Doses)
Figure 18. Global Oral Vaccines Sales Market Share by Application (2017-2022)
Figure 19. Global Oral Vaccines Revenue Market Share by Application in 2021
Figure 20. Oral Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Oral Vaccines Revenue Market Share by Company in 2021
Figure 22. Global Oral Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Oral Vaccines Revenue Market Share by Geographic Region in 2021
Figure 24. Global Oral Vaccines Sales Market Share by Region (2017-2022)
Figure 25. Global Oral Vaccines Revenue Market Share by Country/Region in 2021
Figure 26. Americas Oral Vaccines Sales 2017-2022 (M Doses)
Figure 27. Americas Oral Vaccines Revenue 2017-2022 ($ Millions)
Figure 28. APAC Oral Vaccines Sales 2017-2022 (M Doses)
Figure 29. APAC Oral Vaccines Revenue 2017-2022 ($ Millions)
Figure 30. Europe Oral Vaccines Sales 2017-2022 (M Doses)
Figure 31. Europe Oral Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Oral Vaccines Sales 2017-2022 (M Doses)
Figure 33. Middle East & Africa Oral Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Americas Oral Vaccines Sales Market Share by Country in 2021
Figure 35. Americas Oral Vaccines Revenue Market Share by Country in 2021
Figure 36. United States Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Oral Vaccines Sales Market Share by Region in 2021
Figure 41. APAC Oral Vaccines Revenue Market Share by Regions in 2021
Figure 42. China Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Oral Vaccines Sales Market Share by Country in 2021
Figure 49. Europe Oral Vaccines Revenue Market Share by Country in 2021
Figure 50. Germany Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Oral Vaccines Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Oral Vaccines Revenue Market Share by Country in 2021
Figure 57. Egypt Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Oral Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Oral Vaccines in 2021
Figure 63. Manufacturing Process Analysis of Oral Vaccines
Figure 64. Industry Chain Structure of Oral Vaccines
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
